Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.89M | -54.10K | -355.70K | -874.70K | -296.00K |
| Total Depreciation and Amortization | 40.60K | 40.50K | 40.60K | 65.60K | 51.50K |
| Total Amortization of Deferred Charges | -- | -- | 200.00 | -14.00K | -- |
| Total Other Non-Cash Items | 11.80K | -17.20K | 11.40K | 505.10K | -1.40K |
| Change in Net Operating Assets | 2.08M | 120.50K | 289.40K | 122.10K | -47.20K |
| Cash from Operations | 240.80K | 89.70K | -14.20K | -195.90K | -293.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | -- |
| Total Debt Issued | -- | -- | -- | 200.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 200.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.80K | 89.70K | -14.20K | 4.10K | -293.10K |